iifl-logo

Bal Pharma Ltd EGM

90.49
(0.72%)
Apr 2, 2025|11:39:54 AM

Bal Pharma CORPORATE ACTIONS

02/04/2024calendar-icon
02/04/2025calendar-icon
PurposeAnnouncement DateMeeting Date
EGM20 Nov 202321 Dec 2023
Honorable Bangalore bench of National Company Law Tribunal has convened meetings of shareholders and creditors of Transferer Company i.e Golden Drugs Pvt Ltd and Transferee company i.e Bal Pharma Limited, on 21.12.2023 from 11.00 A.M through audio visual means to inter alia consider approval of scheme of arrangement /merger between transferer Company and Transferee Company. We are submitting to the exchanges newspaper publication of the Notice issued to the Shareholders and Creditors of Bal Pharma Ltd (Transferee Company) and its wholly owned subsidiary Golden Drugs Pvt Ltd (Transferer Company) for the NCLT convened meetings scheduled on 21.12.2023 and published in Financial Express (English) and Vijayavani (Kannada), on 20.11.2023. (As Per BSE Announcement Dated on 21.11.2023) Pursuant to the provisions of Regulation 30 of SEBI (LODR) Regulations ,2015, we are submitting to the exchanges business transacted at the NCLT convened meetings of shareholders, secured and unsecured creditors of the Company, which was conducted through audio visual means on 21.12.2023 (As per BSE Announcement Dated on 21/12/2023) We are submitting to the exchange a copy of the scrutinizers report on the e-voting results of the NCLT convened shareholders meeting of the company held on 21.12.2023. Please take the same on record. (As per BSE Announcement Dated on 22/12/2023)

Bal Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.